ITGAM and neoplasm: Co-treatment with cisplatin and dabigatran etexilate also significantly decreased the population of Gr1+ CD11b+ myeloid derived suppresser cells (MDSC), another major immunosuppressive cell type found in many tumor types (Figure 3B).